| Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells D An, SF Oh, T Olszak, JF Neves, FY Avci, D Erturk-Hasdemir, X Lu, ... Cell 156 (1), 123-133, 2014 | 569 | 2014 |
| The pgaABCD Locus of Acinetobacter baumannii Encodes the Production of Poly-β-1-6-N-Acetylglucosamine, Which Is Critical for Biofilm Formation AHK Choi, L Slamti, FY Avci, GB Pier, T Maira-Litrán Journal of bacteriology 191 (19), 5953-5963, 2009 | 440 | 2009 |
| A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design FY Avci, X Li, M Tsuji, DL Kasper Nature medicine 17 (12), 1602-1609, 2011 | 423 | 2011 |
| How bacterial carbohydrates influence the adaptive immune system FY Avci, DL Kasper Annual review of immunology 28, 107-130, 2009 | 296 | 2009 |
| Enzymatic redesigning of biologically active heparan sulfate J Chen, FY Avci, EM Muñoz, LM McDowell, M Chen, LC Pedersen, ... Journal of Biological Chemistry 280 (52), 42817-42825, 2005 | 157 | 2005 |
| Carbohydrates and T cells: a sweet twosome FY Avci, X Li, M Tsuji, DL Kasper Seminars in immunology 25 (2), 146-151, 2013 | 120 | 2013 |
| Matrix-assisted laser desorption/ionization mass spectrometric analysis of uncomplexed highly sulfated oligosaccharides using ionic liquid matrices TN Laremore, S Murugesan, TJ Park, FY Avci, DV Zagorevski, RJ Linhardt Analytical chemistry 78 (6), 1774-1779, 2006 | 111 | 2006 |
| A maternal vaccine against group B Streptococcus: Past, present, and future VL Chen, FY Avci, DL Kasper Vaccine 31, D13-D19, 2013 | 110 | 2013 |
| Chondroitin sulfate: structure, role and pharmacological activity N Volpi Elsevier, 2006 | 108 | 2006 |
| Microbial carbohydrate depolymerization by antigen-presenting cells: deamination prior to presentation by the MHCII pathway J Duan, FY Avci, DL Kasper Proceedings of the National Academy of Sciences 105 (13), 5183-5188, 2008 | 101 | 2008 |
| Carbohydrates as T-cell antigens with implications in health and disease L Sun, DR Middleton, PL Wantuch, A Ozdilek, FY Avci Glycobiology 26 (10), 1029-1040, 2016 | 86 | 2016 |
| NaCl nanoparticles as a cancer therapeutic W Jiang, L Yin, H Chen, AV Paschall, L Zhang, W Fu, W Zhang, T Todd, ... Advanced Materials 31 (46), 1904058, 2019 | 76 | 2019 |
| CS lyases: structure, activity, and applications in analysis and the treatment of diseases RJ Linhardt, FY Avci, T Toida, YS Kim, M Cygler Advances in pharmacology 53, 187-215, 2006 | 67 | 2006 |
| Enzymatic synthesis of heparin related polysaccharides on sensor chips: rapid screening of heparin–protein interactions E Muñoz, D Xu, F Avci, M Kemp, J Liu, RJ Linhardt Biochemical and biophysical research communications 339 (2), 597-602, 2006 | 63 | 2006 |
| Synthetic oligosaccharides as heparin-mimetics displaying anticoagulant properties FY Avci, NA Karst, RJ Linhardt Current pharmaceutical design 9 (28), 2323-2335, 2003 | 59 | 2003 |
| FAP‐targeted photodynamic therapy mediated by ferritin nanoparticles elicits an immune response against cancer cells and cancer associated fibroblasts S Zhou, Z Zhen, AV Paschall, L Xue, X Yang, AG Bebin Blackwell, Z Cao, ... Advanced functional materials 31 (7), 2007017, 2021 | 52 | 2021 |
| Rapid screening of sugar-nucleotide donor specificities of putative glycosyltransferases MO Sheikh, SM Halmo, S Patel, D Middleton, H Takeuchi, CM Schafer, ... Glycobiology 27 (3), 206-212, 2017 | 50 | 2017 |
| Current status and future directions of invasive pneumococcal diseases and prophylactic approaches to control them PL Wantuch, FY Avci Human vaccines & immunotherapeutics 14 (9), 2303-2309, 2018 | 49 | 2018 |
| Isolation of carbohydrate-specific CD4+ T cell clones from mice after stimulation by two model glycoconjugate vaccines FY Avci, X Li, M Tsuji, DL Kasper Nature protocols 7 (12), 2180-2192, 2012 | 48 | 2012 |
| Preparation of the methyl ester of hyaluronan and its enzymatic degradation K Hirano, S Sakai, T Ishikawa, FY Avci, RJ Linhardt, T Toida Carbohydrate research 340 (14), 2297-2304, 2005 | 46 | 2005 |
